Cancer drug firm Carrick to begin ‘multi-portfolio’ clinical trials within year

Cancer drug firm Carrick to begin ‘multi-portfolio’ clinical trials within year
Elaine Sullivan

Dublin-based firm aiming to fight aggressive forms of cancer has raised $95m from investors

Carrick Therapeutics, the Dublin-headquartered drug company launched last week, said it hopes to have its compounds for cancer treatments undergoing clinical trial in a year.

Co-founder Elaine Sullivan told The Sunday Business Post that the company was currently working with scientists on programmes to target three areas – using “molecular pathways” – to fight some of the most aggressive forms of cancer.

“We want to create a multi-portfolio [drug] company and we identified three assets and...

Subscribe from just 1€

Exclusive offers

Choose the subscription that is right for you

Monthly Subscription

€1

For the first month

€19.99 Monthly Thereafter

Subscribe today

Cancel anytime

Annual Subscription

€200€149

For the first year

€199.99 annually thereafter

Subscribe today

Cancel anytime

Quarterly Subscription

€55€42

For the first 90 days

€55.00 quarterly Thereafter

Subscribe today

Cancel anytime

These offers are not available for current subscribers. Offers and pricing are subject to change without notice.

Terms & Conditions Apply

Please Subscribe or Log in to continue

Subscribe Login

Related Articles

More from The Business Post